Resveratrol STUDIES

Highlights Randomized, double-blind, placebo-controlled, cross-over trial involving 21 older adults  Supplementation consist of ResVida 99% pure, all-trans resveratrol supplementation (200 mg/day, twice daily) for 6 weeks (treatment and matching placebo provided by Endurance Products...

Highlights Randomized, double-blind, controlled, cross-over trial Resveratrol supplementation: single doses (30, 90 and 270 mg) All resveratrol amounts promote optimal endothelial function compared to placebo Summary This randomized, double-blind, controlled, cross-over...

Highlights Meta-analysis of 17 randomized, controlled trials (736 participants) Resveratrol supplementation significantly reduces TNF-alpha and C-reactive protein Median dosage is 300 mg/day for 2 months   Summary This meta-analysis was performed...

Highlights Meta-analysis with 11 randomized, controlled clinical trials Median resveratrol supplement intake is 100 mg/day for 12 weeks Resveratrol supports glucose balance and insulin function  Summary This meta-analysis was designed...

Highlights Randomized, double-blind, placebo-controlled trial Supplementation consists of trans-resveratrol (500 mg/day) for 6 weeks Resveratrol promotes optimal antioxidant status  Summary  This randomized, double-blind, placebo-controlled trial was designed to examine the antioxidant...